Red Yeast Rice and Phytosterols In Statin Intolerance

Sponsor
Chestnut Hill Health System (Other)
Overall Status
Completed
CT.gov ID
NCT00897975
Collaborator
(none)
200
2
4
24
100
4.2

Study Details

Study Description

Brief Summary

Red yeast rice may be useful to lower cholesterol, especially in a population of patients who cannot tolerate traditional therapy with statins.

The addition of an over-the-counter phytosterol to red yeast rice may offer additional lipid lowering benefits when compared to red yeast rice alone.

These supplements will be given to all participants. Up to one-half will enroll in a lifestyle intervention program called Change of Heart and will be compared to patients who do not participate in the program. The study will last one year.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: red yeast rice
  • Drug: phytosterol
  • Behavioral: therapeutic lifestyle program
  • Drug: placebo
Phase 2/Phase 3

Detailed Description

Although recent studies have shown that red yeast rice is an effective therapy in the treatment of hyperlipidemia, additional supplements may be required to lower cholesterol to levels that have been associated with decreased coronary events. Specifically a target has been to lower low-density lipoprotein-C (LDL-C) to levels below 100 mg/dl. Red yeast rice has been found to be effective in lowering cholesterol in the context of the Change of Heart Program, where participants are encouraged to make significant lifestyle changes. This has been documented in two recent trials that we have published in the past year in the Mayo Clinic Proceedings (July 2008) and The Annals of Internal Medicine (in press). Clinically, we have found it necessary to add a phytosterol supplement to red yeast rice to lower LDL-C levels below 100 mg/dl. There has been a great deal of interest in phytosterols in both the lay and medical press in the past several years. This over the counter supplement lowers cholesterol by acting in the intestine to decrease the absorption of cholesterol. As it is not absorbed, there have not been any reports of significant side effects. The purpose of this study is to examine the lipid lowering effects of red yeast rice with and without adding a phytosterol. Some participants will attend the Change of Heart Program and take these supplements. Another group of participants will take the same supplements, with their usual medical care, but not enroll in the Change of Heart Program. The study will last one year, and participants will have been intolerant of statins in the past.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Red Yeast Rice and Phytosterols Versus Red Yeast Rice and Placebo for the Treatment of Hyperlipidemia in Patients With Statin Intolerance: A Multi-Center Randomized Double-blind Study
Study Start Date :
Jul 1, 2009
Actual Primary Completion Date :
Nov 1, 2010
Actual Study Completion Date :
Jul 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: red yeast rice (RYR) plus phytosterol

arm will take red yeast rice and phytosterol supplement

Dietary Supplement: red yeast rice
600 mg 3 capsules bid

Drug: phytosterol
phytosterol 450 mg 2 tabs bid with food

Placebo Comparator: red yeast rice plus placebo

Dietary Supplement: red yeast rice
600 mg 3 capsules bid

Drug: placebo
placebo

Active Comparator: TLC plus red yeast rice plus placebo

subjects attend 12 week therapeutic lifestyle program and take above supplement

Dietary Supplement: red yeast rice
600 mg 3 capsules bid

Behavioral: therapeutic lifestyle program
TLC - 12 weeks

Drug: placebo
placebo

Experimental: TLC plus RYR plus phytosterol

Therapeutic lifestyle program for 12 weeks plus red yeast rice plus phytosterol

Dietary Supplement: red yeast rice
600 mg 3 capsules bid

Drug: phytosterol
phytosterol 450 mg 2 tabs bid with food

Behavioral: therapeutic lifestyle program
TLC - 12 weeks

Outcome Measures

Primary Outcome Measures

  1. LDL cholesterol levels [one year]

Secondary Outcome Measures

  1. myalgia compared to prior statin usage [one year]

  2. other lipoprotein levels [one year]

  3. weight loss in TLC program vs. baseline [one year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Men and women age > 21

  • LDL > 100 and physician suggestion to take statin

  • Subject complains of muscle weakness or aching which he/she or his/her physician feels may be attributable to statin therapy

  • Having stopped a statin drug for personal reasons and not willing to restart this medication

  • Refusal to take a statin as prescribed by personal physician

  • CPK < 400

  • Not taking any cholesterol lowering medication, red yeast rice extract or a phytosterol product for at least 1 month prior to initiation of trial

  • Ability to exercise without physical restrictions

  • Ability to attend 12 week consecutive Change of Heart lifestyle education sessions

  • Liver function studies normal at baseline

  • Subject willing to remain off the dietary supplement CoQ10 for duration of trial

  • TSH must be normal

Exclusion Criteria:
  • A history of muscle damage (CPK > 400 IU) on statin therapy

  • Any active cardiac problem including chest pain, angina, shortness of breath with minimal activity, or unstable angina/acute coronary syndrome within one year

  • Known intolerance to one of the study drugs

  • Physical limitation preventing aerobic exercise program, such as severe arthritis, peripheral vascular disease, congestive heart failure, or symptom limiting pulmonary disease

  • Uncontrolled hypertension (defined as SBP > 180 mmHg or DBP > 100 mmHg

  • Heart attack, bypass surgery, or angioplasty/stent within 1 year of study

  • Triglyceride level more than 400 mg/dl

  • Underlying musculoskeletal disorder preventing muscle testing

  • Taking other medicines including: cyclosporine, erythromycin or other macrolide antibiotics; fluconazole; niacin; fibrates; or > 16 oz. of grapefruit juice daily

Contacts and Locations

Locations

Site City State Country Postal Code
1 Abington Memorial Hospital Abington Pennsylvania United States
2 Chestnut Hill Hospital Philadelphia Pennsylvania United States 19118

Sponsors and Collaborators

  • Chestnut Hill Health System

Investigators

  • Principal Investigator: David J Becker, MD, Chestnut Hill Heathcare

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00897975
Other Study ID Numbers:
  • FWA00005390 Chestnut HillHC
First Posted:
May 12, 2009
Last Update Posted:
Jul 18, 2011
Last Verified:
Nov 1, 2009

Study Results

No Results Posted as of Jul 18, 2011